Back to Inflammatory Myofibroblastic Tumor

Inflammatory Myofibroblastic Tumor — Clinical Trials

MONDO:00157982 active·1 recruitingLast updated: Mar 20, 2026, 6:31 AM

Trial Landscape

Inflammatory Myofibroblastic Tumor has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment2

Procedure1

By Phase

Phase 1

Phase 2

Phase 3

Sponsor Types

NIH1Academic/Other1

Trial Locations

United States1 trial

Canada1 trial

Puerto Rico1 trial

France1 trial

Netherlands1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

2 Trials

Phase 1Recruiting

NCT04925609

Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors

Sponsor:Princess Maxima Center for Pediatric Oncology

FranceStarted: Aug 2022Est. completion: Dec 2033Updated: Dec 2025

Phase 2Active, Not Recruiting

NCT02180867

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Jul 2014Est. completion: Dec 2026Updated: Mar 2026

Stay informed about clinical trials for Inflammatory Myofibroblastic Tumor.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 20, 2026 at 6:31 AM